| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abarelix (Plenaxis™): A Gonadotropin-Releasing Hormone Antagonist for Medical Castration in Patients with Advanced Prostate Cancer
|
Reddy, G. Kesava
|
|
2004
|
2 |
4 |
p. 209-211
3 p.
|
artikel
|
| 2 |
An Evaluation of Bicalutamide in the Treatment of Prostate Cancer
|
Schellhammer, Paul F.
|
|
2004
|
2 |
4 |
p. 213-219
7 p.
|
artikel
|
| 3 |
A Phase I Study of Oral CC-5013(Lenalidomide, Revlimid™), a Thalidomide Derivative, in Patients with Refractory Metastatic Cancer
|
Tohnya, Tanyifor M.
|
|
2004
|
2 |
4 |
p. 241-243
3 p.
|
artikel
|
| 4 |
Biochemical Recurrence and Survival Prediction Models for the Management of Clinically Localized Prostate Cancer
|
Tewari, Ashutosh
|
|
2004
|
2 |
4 |
p. 220-227
8 p.
|
artikel
|
| 5 |
Current Status of Prostate Cancer Management in the Prostate-Specific Antigen Era
|
Sartor, Oliver
|
|
2004
|
2 |
4 |
p. 200-201
2 p.
|
artikel
|
| 6 |
Does Finasteride Alter the Pathology of the Prostate and Cancer Grading?
|
Bostwick, David G.
|
|
2004
|
2 |
4 |
p. 228-235
8 p.
|
artikel
|
| 7 |
Finasteride, a Selective 5-Alpha-Reductase Inhibitor, in the Prevention and Treatment of Human Prostate Cancer
|
Reddy, G. Kesava
|
|
2004
|
2 |
4 |
p. 206-208
3 p.
|
artikel
|
| 8 |
Geriatric Assessment in Elderly Patients with Prostate Cancer
|
Terret, Catherine
|
|
2004
|
2 |
4 |
p. 236-240
5 p.
|
artikel
|
| 9 |
Improved Survival Benefit of Autologous Dendritic Cell–Based Vaccine for Hormone Refractory Prostate Cancer: A Retrospective Subset Analysis of the D9901 Trial
|
Price, Nancy
|
|
2004
|
2 |
4 |
p. 212-
1 p.
|
artikel
|
| 10 |
The Development of Vitamin D–Based Therapies for Prostate Cancer
|
Price, Nancy
|
|
2004
|
2 |
4 |
p. 202-205
4 p.
|
artikel
|
Tijdschrift beschrijving